Literature DB >> 410821

Abnormalities in the regulation of prolactin in patients with chronic renal failure.

G Ramirez, W M O'Neill, H A Bloomer, W Jubiz.   

Abstract

We have investigated the hypothalamic-hypophyseal regulation of prolactin secretion in patients with chronic renal failure treated with chronic hemodialysis. When compared to control subjects, baseline serum prolactin levels were elevated in the renal failure patients (range 11 to 16 mmicrogram/ml for renal failure patients, 6 to 9 mmicrogram/ml for controls, P less than 0.05). In addition, serum prolactin levels in the renal failure patients failed to suppress significantly following the administration of L-dopa, and did not increase in response to chlorpromazine or thyrotropin releasing hormone. These findings suggest an abnormal regulation of prolactin secretion and appear to be another example of the endocrine dysfunction that occurs in uremic subjects.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 410821     DOI: 10.1210/jcem-45-4-658

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

Review 1.  Hormonal derangements in uremia.

Authors:  G Tolis; D Goltzman; H Guyda; T Mountokalakis
Journal:  J Endocrinol Invest       Date:  1980 Jan-Mar       Impact factor: 4.256

Review 2.  Control of prolactin secretion.

Authors:  G Benker; C Jaspers; G Häusler; D Reinwein
Journal:  Klin Wochenschr       Date:  1990-12-04

3.  Altered growth hormone response after growth hormone releasing hormone administration in chronic renal failure.

Authors:  R V Garcia; A Andrade; J Perez; M Courel; F F Casanueva
Journal:  J Endocrinol Invest       Date:  1991-05       Impact factor: 4.256

Review 4.  Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications.

Authors:  E E Müller; M Rolla; E Ghigo; D Belliti; E Arvat; A Andreoni; A Torsello; V Locatelli; F Camanni
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

5.  Effect of 1,25-dihydroxyvitamin D3 on plasma prolactin in patients with renal failure on regular dialysis treatment.

Authors:  D Verbeelen; L Vanhaelst; A C Van Steirteghem; J Sennesael
Journal:  J Endocrinol Invest       Date:  1983-10       Impact factor: 4.256

Review 6.  Role of the kidney in hormone metabolism and its implications in clinical medicine.

Authors:  D S Emmanouel; M D Lindheimer; A I Katz
Journal:  Klin Wochenschr       Date:  1980-10-01

7.  Lack of dissociation of prolactin responses to thyrotropin releasing hormone and metoclopramide in chronic alcoholic men.

Authors:  D H Van Thiel; J S Gavaler; A Sanghvi
Journal:  J Endocrinol Invest       Date:  1982 Sep-Oct       Impact factor: 4.256

8.  A prospective analysis of testicular androgenic function in recipients of a renal allograft.

Authors:  Rajiv Yadav; S N Mehta; A Kumar; S Guleria; V Seenu; S C Tiwari
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

9.  [Disorders of hormone metabolism in chronic uremia].

Authors:  M Weissel; H K Stummvoll
Journal:  Klin Wochenschr       Date:  1983-05-16

10.  Hyperprolactinaemia--investigation and results of treatment.

Authors:  J D Wilson; D D Boyle; J M Harley; D A Montgomery; B Sheridan
Journal:  Ulster Med J       Date:  1980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.